Abera Bioscience AB is a Swedish biotech company headquartered in Uppsala. We are dedicated to develop novel mucosal vaccines based on proprietary vaccine platforms to improve health worldwide.
Abera's platforms allows the development of efficient multivalent, multi-stage vaccines for oral and nasal administration. It also enables faster and more cost-effective production. Abera's OMV-based vaccines can be manufactured within 14-30 days.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Virdings Allé, Uppsala,uppsala County 754 50,sweden
- Phone
- +46 72 231 17 97
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aberabio.com
- Keywords
- Vaccine Delivery Platform, Vaccine Development, Outer Membrane Vesicles (OMV), Autotransporters.
- HQ
- Uppsala, Uppsala County
Abera Bioscience Ab Questions
Abera Bioscience Ab's helpline number is +46 72 231 17 97
Abera Bioscience Ab's website is aberabio.com
Abera Bioscience Ab's LinkedIn profile is https://se.linkedin.com/company/abera-bioscience-ab
Abera Bioscience Ab has
12 employees.
View email and phone details for 12
employees at Abera Bioscience Ab.
Abera Bioscience Ab's industry is
Biotechnology Research
Abera Bioscience Ab's top competitors are
Northx Biologics,
Cepi (Coalition For Epidemic Preparedness Innovations),
Bioarctic,
Atmp Sweden,
Orexo Ab Publ.,
Aax Biotech Ab,
Cavidi,
Affibody Ab,
Abliva Ab,
Rarity Bioscience.
Abera Bioscience Ab's categories are Biotechnology Research
Abera Bioscience Ab's founding year is 2012
